The Prioritization of Anti-Counterfeiting Measures in Developing Countries [Heat Map]

The Prioritization of Anti-Counterfeiting Measures in Developing Countries [Heat Map]

Developing countries are the worst affected from counterfeit pharmaceuticals, regulatory structures are weaker and measurement and oversight is difficult. According to the World Health Organization, an estimated 1 in 10 medical products in low- and middle-income countries is substandard or falsified. This heat map specifically focuses in on the largest counterfeiting markets: Africa, China, and India. Download this map to learn about the latest advancements developing countries have taken to combat anti-counterfeiting and which country needs to start making it a priority.


Please note: That all fields marked with an asterisk (*) are required.